Medicine and Dentistry
Lung Cancer
100%
Resistance Mutation
58%
Epidermal Growth Factor Receptor
50%
Formaldehyde
50%
Tyrosine-Kinase Inhibitor
50%
ALK Inhibitor
50%
Fusion Gene
50%
Non Small Cell Lung Cancer
36%
Biopsy Technique
30%
Neoplasm
30%
Droplet Digital Polymerase Chain Reaction
28%
Progression Free Survival
16%
Leukocyte
16%
Protein Tyrosine Kinase
10%
Survival Time
8%
Gene Frequency
8%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Protein Tyrosine Kinase Inhibitor
50%
Epidermal Growth Factor Receptor
50%
Formaldehyde
50%
Anaplastic Lymphoma Kinase Inhibitor
50%
Non Small Cell Lung Cancer
36%
Neoplasm
30%
Progression Free Survival
16%
Protein Tyrosine Kinase
10%
Survival Time
8%
Biochemistry, Genetics and Molecular Biology
Droplet Digital Polymerase Chain Reaction
60%
Tyrosine Kinase Inhibitor
50%
Epidermal Growth Factor Receptor
50%
Fusion Gene
50%
Tyrosine Kinase
25%
Receptor Tyrosine Kinase
25%
Leukocyte
20%
Progression Free Survival
20%
Gene Frequency
10%
Survival Time
10%
